FDA approves revolutionary cancer drug

The FDA has approved Vitrakvi for adult and pediatric patients whose cancers have a specific biomarker. (Photo: Bayer)

(CNN) – The FDA has approved what could be a breakthrough drug in the treatment of certain cancers.

His name is Vitrakvi.

The drug is designed to fight against a specific genetic mutation in certain forms of cancer.

And it comes in an easy-to-take capsule or liquid form.

Doctors say that some patients, including children, have experienced remarkable reversals.

But they warn that it does not work for all cancers and that it is expensive!

"We are now able to ensure that the right patients receive the right treatment at the right time. This type of drug development program, which included patients with different tumors but with a common gene mutation, would not have been possible ten years ago because we knew much less about these mutations. cancerous. Dr. Scott Gottlieb, Commissioner of the FDA, said.

The wholesale price of syrup for children is $ 11,000 per month.

And adult oral capsules wholesale for $ 32,000 a month.

But with insurance, most patients would pay $ 20.00 or less for a 30-day drug supply.

Source link